Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2000;84:494-498; doi:10.1136/heart.84.5.494
Copyright © 2000 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2000;84:494-498 ( November )

Cardiovascular medicine

Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound: correlation to immunological and non-immunological risk factors K Pethiga, V Klaussb, B Heubleina, H Mudrab, A Westphala, C Weberb, K Theisenb, A Havericha

a Department of Thoracic and Cardiovascular Surgery, Division of Surgery, Hannover Medical School, D-30623 Hannover, Germany, b Department of Internal Medicine, Division of Cardiology, Klinikum Innenstadt, University of Munich, Munich, Germany

Correspondence to: Dr Pethig Klaus.Pethig{at}thg.mh-hannover.de

Accepted 12 July 2000

OBJECTIVE---To characterise the severity and progression of cardiac allograft vascular disease (CAVD) in a large patient cohort, and to evaluate possible immunological and non-immunological risk factors for progression.
DESIGN---A prospective observational study using intravascular ultrasound.
SETTING---Two university hospitals.
PATIENTS AND MAIN OUTCOME MEASURES---Changes in focal plaque, lumen, and total vessel area (worst site method) were assessed at baseline and after 12.1 (2.8) months (mean (SD)) of follow up in a cohort of 96 patients (79 male, 17 female; mean age 48.7 (9.6) years; time post-transplant 26.0 (32.4) months).
RESULTS---Overall, the mean (SD) intimal index of worst sites increased by 6.7 (8.8)%. The increase in the first 12 months was 7.5 (9.4)%, v 5.9 (8.0)% after the first year (NS). Analysing immunological and non-immunological risk factors (age, underlying disease, sex, donor age, immunosuppression, cytomegalovirus, rejection episodes, cholesterol), low density lipoprotein (LDL) cholesterol was found to be the most important predictor of severe progression (as defined by an increase in intimal index of >=  15% (p = 0.01).
CONCLUSIONS---Progression of CAVD is characterised by a continuing increase in intimal hyperplasia, especially within the first year after heart transplantation. LDL cholesterol is an important predictor of major progression.


Keywords: heart transplantation; cardiac allograft vasculopathy; intravascular ultrasound


© 2000 by Heart

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Zakliczynski, M., Nozynski, J., Konecka-Mrowka, D., Krynicka-Mazurek, A., Swierad, M., Maruszewski, M., Przybylski, R., Zembala, M. (2009). Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: Are they related to the development of cardiac allograft vasculopathy?. J. Thorac. Cardiovasc. Surg. 138: 215-221 [Abstract] [Full Text]  
  • Yousufuddin, M., Cook, D. J., Starling, R. C., Abdo, A., Paul, P., Tuzcu, E. M., Ratliff, N. B., McCarthy, P. M., Young, J. B., Yamani, M. H. (2004). Angiotensin II receptors from peritransplantation through first-year post-transplantation and the risk of transplant coronary artery disease. J Am Coll Cardiol 43: 1565-1573 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.